数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Nicole Seligman 女 Independent Director 69 未披露 未持股 2026-03-27
Erica Dorfman 女 Independent Director 36 未披露 未持股 2026-03-27
Peter Ondishin 男 Chief Financial Officer and Director 39 未披露 未持股 2026-03-27
Justin Di Rezze 男 Chief Executive Officer and Director 38 未披露 843.33 2026-03-27
Alex Elias 男 Independent Director 38 未披露 未持股 2026-03-27

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Peter Ondishin 男 Chief Financial Officer and Director 39 未披露 未持股 2026-03-27
Justin Di Rezze 男 Chief Executive Officer and Director 38 未披露 843.33 2026-03-27

董事简历

中英对照 |  中文 |  英文
Nicole Seligman

Nicole Seligman,她一直担任Far Point Acquisition Corporation董事(2018年6月以来)。自2019年以来,她一直是MeiraGTx的董事会成员。自2016年8月以来,她一直担任Viacom, Inc.和现在的Viacom CBS的董事会成员,在那里她担任提名和治理委员会主席。自2014年1月以来,她一直担任WPP PLC的董事会成员,并于2016年4月起担任高级独立董事。直到2016年3月,她曾担任Sony Entertainment, Inc.的总裁公司(2014年开始)和Sony Corporation of America的总裁公司(2012年开始),以及Sony Group的高级法律顾问(2014年开始)。从2005年到2014年,她曾担任Sony Corporation的执行副总裁和总法律顾问。她于2001年加入索尼,并在任职期间担任多种职务。加入Sony之前,Seligman女士是华盛顿特区Williams & Connolly LLP的诉讼执业合伙人,在那里她从事广泛的复杂民事和刑事事务,并代表广泛的客户,包括William Jefferson Clinton总统。她于1985年加入Williams & Connolly。1984年至1985年,她担任美国最高法院大法官Thurgood Marshall的法律助理;1983年至1984年,担任美国哥伦比亚特区上诉法院法官Harry T. Edwards的法律助理。她以优异成绩毕业于哈佛法学院,并获得西尔斯奖。


Nicole Seligman has served on Board since the commencement of listing on Nasdaq. Ms. Seligman is a globally recognized corporate leader and a lawyer. Ms. Seligman currently serves as a member of the board of directors of Intuitive Machines, Inc., a space technology, infrastructure, and services company since 2023, and MeiraGTx Holdings PLC, a clinical stage gene therapy company since 2019. In addition, she serves on the board of directors of OpenAI, a non profit organization with a mission to ensure that artificial general intelligence benefits all of humanity, since 2024, as well as on the board of directors of OpenAI Group PBC, which is a for profit public benefit corporation controlled by OpenAI, since 2025. She also serves on the board of directors of several additional organizations, including as Co Chair of the Board of Trustees of the Schwarzman Animal Medical Center (New York), the world's largest non profit animal hospital, and Chair of the Board of The Doe Fund, a NYC nonprofit that transitions homeless and formerly incarcerated individuals to independent lives among other non profit organizations. Ms. Seligman served as a member of the board of directors of Paramount Global (formerly known as Viacom Inc. and subsequently ViacomCBS Inc.) from 2016 to 2024. She also served on the board of Far Peak Acquisition Corporation from 2021 to 2023 and WPP PLC from 2014 to 2023. Ms. Seligman held various senior executive roles at Sony Corporation from 2001 to 2016, including serving as Executive Vice President and Global General Counsel of Sony Corporation from 2005 to 2014 and as President of Sony Entertainment, Inc., from 2014 to 2016. Prior to joining Sony, Ms. Seligman was a partner in the litigation practice at Williams & Connolly LLP working on complex civil and criminal matters including for President Bill Clinton and Hillary Clinton.
Nicole Seligman,她一直担任Far Point Acquisition Corporation董事(2018年6月以来)。自2019年以来,她一直是MeiraGTx的董事会成员。自2016年8月以来,她一直担任Viacom, Inc.和现在的Viacom CBS的董事会成员,在那里她担任提名和治理委员会主席。自2014年1月以来,她一直担任WPP PLC的董事会成员,并于2016年4月起担任高级独立董事。直到2016年3月,她曾担任Sony Entertainment, Inc.的总裁公司(2014年开始)和Sony Corporation of America的总裁公司(2012年开始),以及Sony Group的高级法律顾问(2014年开始)。从2005年到2014年,她曾担任Sony Corporation的执行副总裁和总法律顾问。她于2001年加入索尼,并在任职期间担任多种职务。加入Sony之前,Seligman女士是华盛顿特区Williams & Connolly LLP的诉讼执业合伙人,在那里她从事广泛的复杂民事和刑事事务,并代表广泛的客户,包括William Jefferson Clinton总统。她于1985年加入Williams & Connolly。1984年至1985年,她担任美国最高法院大法官Thurgood Marshall的法律助理;1983年至1984年,担任美国哥伦比亚特区上诉法院法官Harry T. Edwards的法律助理。她以优异成绩毕业于哈佛法学院,并获得西尔斯奖。
Nicole Seligman has served on Board since the commencement of listing on Nasdaq. Ms. Seligman is a globally recognized corporate leader and a lawyer. Ms. Seligman currently serves as a member of the board of directors of Intuitive Machines, Inc., a space technology, infrastructure, and services company since 2023, and MeiraGTx Holdings PLC, a clinical stage gene therapy company since 2019. In addition, she serves on the board of directors of OpenAI, a non profit organization with a mission to ensure that artificial general intelligence benefits all of humanity, since 2024, as well as on the board of directors of OpenAI Group PBC, which is a for profit public benefit corporation controlled by OpenAI, since 2025. She also serves on the board of directors of several additional organizations, including as Co Chair of the Board of Trustees of the Schwarzman Animal Medical Center (New York), the world's largest non profit animal hospital, and Chair of the Board of The Doe Fund, a NYC nonprofit that transitions homeless and formerly incarcerated individuals to independent lives among other non profit organizations. Ms. Seligman served as a member of the board of directors of Paramount Global (formerly known as Viacom Inc. and subsequently ViacomCBS Inc.) from 2016 to 2024. She also served on the board of Far Peak Acquisition Corporation from 2021 to 2023 and WPP PLC from 2014 to 2023. Ms. Seligman held various senior executive roles at Sony Corporation from 2001 to 2016, including serving as Executive Vice President and Global General Counsel of Sony Corporation from 2005 to 2014 and as President of Sony Entertainment, Inc., from 2014 to 2016. Prior to joining Sony, Ms. Seligman was a partner in the litigation practice at Williams & Connolly LLP working on complex civil and criminal matters including for President Bill Clinton and Hillary Clinton.
Erica Dorfman

Erica Dorfman,自2023年5月24日起担任Inflection Point Acquisition Corp.董事会成员。她目前担任Brex全球金融产品主管,负责开发涵盖信用卡、支付、现金流动、报销、信用额度、账单和定价的金融产品。她曾在2019年至2022年期间担任Brex Cash总裁,并领导了Brex的银行章程申请。Dorfman女士曾在2018年至2019年期间担任Tally Technologies的首席财务官和首席运营官,在那里她为该公司获得了由Andreessen Horowitz主持的5000万美元C轮融资。在加入Tally Technologies之前,多尔夫曼曾在2016年至2018年期间担任SoFi资本市场副总裁,负责资产出售、银行和资产管理公司仓库等超过100亿美元的交易,以及学生贷款、消费者无抵押贷款和抵押贷款等15多项证券化交易。2013年至2016年,多夫曼在BDT Capital Partners担任私募股权合伙人,2011年至2013年,她开始在摩根大通从事投资银行业务,覆盖工业企业。多夫曼是一位天使投资人,个人投资于金融科技和B2B软件。她在2019年获得了《福布斯》30位30岁以下青年的表彰。


Erica Dorfman has served on Board since the commencement of listing on Nasdaq. Ms. Dorfman currently serves as the Chief Financial Officer for Brex Inc., a financial management platform, a position in which she has served since August 2025. Previously, Ms. Dorfman served as the Senior Vice President of Global Financial Products for Brex Inc. since 2019. Prior to her time at Brex Inc., Ms. Dorfman served as the president of Brex Cash from 2019 to 2022. Additionally, Ms. Dorfman served as a member of the board of directors of Inflection Point Acquisition Corp. II, a special purpose acquisition company from May 2023 to March 2025.
Erica Dorfman,自2023年5月24日起担任Inflection Point Acquisition Corp.董事会成员。她目前担任Brex全球金融产品主管,负责开发涵盖信用卡、支付、现金流动、报销、信用额度、账单和定价的金融产品。她曾在2019年至2022年期间担任Brex Cash总裁,并领导了Brex的银行章程申请。Dorfman女士曾在2018年至2019年期间担任Tally Technologies的首席财务官和首席运营官,在那里她为该公司获得了由Andreessen Horowitz主持的5000万美元C轮融资。在加入Tally Technologies之前,多尔夫曼曾在2016年至2018年期间担任SoFi资本市场副总裁,负责资产出售、银行和资产管理公司仓库等超过100亿美元的交易,以及学生贷款、消费者无抵押贷款和抵押贷款等15多项证券化交易。2013年至2016年,多夫曼在BDT Capital Partners担任私募股权合伙人,2011年至2013年,她开始在摩根大通从事投资银行业务,覆盖工业企业。多夫曼是一位天使投资人,个人投资于金融科技和B2B软件。她在2019年获得了《福布斯》30位30岁以下青年的表彰。
Erica Dorfman has served on Board since the commencement of listing on Nasdaq. Ms. Dorfman currently serves as the Chief Financial Officer for Brex Inc., a financial management platform, a position in which she has served since August 2025. Previously, Ms. Dorfman served as the Senior Vice President of Global Financial Products for Brex Inc. since 2019. Prior to her time at Brex Inc., Ms. Dorfman served as the president of Brex Cash from 2019 to 2022. Additionally, Ms. Dorfman served as a member of the board of directors of Inflection Point Acquisition Corp. II, a special purpose acquisition company from May 2023 to March 2025.
Peter Ondishin

Peter Ondishin,自2023年3月起担任IPXX的CFO,此前为IPAX员工。Ondishin先生自2023年6月起担任Venture Collective的CFO,自2023年4月起担任IPXX的CFO,自2020年8月起担任Kingstown Capital Management的CFO,此前他曾于2019年4月至2020年8月担任Kingstown的财务总监。Ondishin先生在2016年1月至2019年3月期间担任Atlantic Investment Management的助理财务总监。在此之前,Ondishin先生于2014年1月至2016年1月期间担任Fir Tree Partners的会计师。翁迪辛先生的职业生涯始于普华永道的保险业。Ondishin先生拥有罗格斯大学的学士学位和MBA学位,他也是注册会计师。


Peter Ondishin has been Inflection Point Acquisition Corp. Iii's CFO since November 2024. He has served as CFO of IPXX from March 2023 to March 2025, and he was previously an employee of IPAX. Mr. Ondishin has been the CFO of The Venture Collective since June 2023. He was previously the CFO of Kingstown Capital Management from August 2020 to December 2023 and the Controller of Kingstown from April 2019 to August 2020. Mr. Ondishin was the Assistant Controller for Atlantic Investment Management from January 2016 to March 2019. Before that, Mr. Ondishin worked as an accountant for Fir Tree Partners from January 2014 to January 2016. Mr. Ondishin began his career in assurance at PwC. Mr. Ondishin holds a B.A. and an M.B.A. from Rutgers University, and he is also Certified Public Accountant.
Peter Ondishin,自2023年3月起担任IPXX的CFO,此前为IPAX员工。Ondishin先生自2023年6月起担任Venture Collective的CFO,自2023年4月起担任IPXX的CFO,自2020年8月起担任Kingstown Capital Management的CFO,此前他曾于2019年4月至2020年8月担任Kingstown的财务总监。Ondishin先生在2016年1月至2019年3月期间担任Atlantic Investment Management的助理财务总监。在此之前,Ondishin先生于2014年1月至2016年1月期间担任Fir Tree Partners的会计师。翁迪辛先生的职业生涯始于普华永道的保险业。Ondishin先生拥有罗格斯大学的学士学位和MBA学位,他也是注册会计师。
Peter Ondishin has been Inflection Point Acquisition Corp. Iii's CFO since November 2024. He has served as CFO of IPXX from March 2023 to March 2025, and he was previously an employee of IPAX. Mr. Ondishin has been the CFO of The Venture Collective since June 2023. He was previously the CFO of Kingstown Capital Management from August 2020 to December 2023 and the Controller of Kingstown from April 2019 to August 2020. Mr. Ondishin was the Assistant Controller for Atlantic Investment Management from January 2016 to March 2019. Before that, Mr. Ondishin worked as an accountant for Fir Tree Partners from January 2014 to January 2016. Mr. Ondishin began his career in assurance at PwC. Mr. Ondishin holds a B.A. and an M.B.A. from Rutgers University, and he is also Certified Public Accountant.
Justin Di Rezze

Jtin Di Rezze自2025年9月29日成立以来一直担任公司首席执行官和董事,并且是保荐人Praetorian Sponsor LLC的管理成员,预计将担任公司董事。Di Rezze博士是Theoria Medical的创始人和前任首席执行官,Theoria Medical是一家全国性的医师服务和医疗保健技术组织,业务涵盖专业护理设施、辅助生活中心和远程医疗网络,后者是美国最大的急性后护理提供商之一。从2019年5月到2025年8月,Di Rezze博士通过其在医疗保健运营、财务监督和公司治理方面的丰富经验,实现了收入的显着增长,并增加了供应商的足迹和质量成果。他的背景将临床培训与在医疗保健交付和技术创新方面的深厚战略和运营专业知识相结合。Di Rezze博士拥有底特律仁慈大学的文学学士学位和韦恩州立大学医学院的医学博士学位。Di Rezze将有资格担任首席执行官和董事会成员,这是由于他在构建可扩展的医疗保健企业方面的良好记录、在实施robt治理框架方面的领导能力,以及他对医疗保健、金融和技术融合的全面理解。


Justin Di Rezze has served as Chief Executive Officer and as a director of Company since incorporation on September 29, 2025 and is the managing member of Sponsor, Praetorian Sponsor LLC. Dr. Di Rezze is the founder and former Chief Executive Officer of Theoria Medical, a national physician services and healthcare technology organization operating across skilled nursing facilities, assisted living centers, and telehealth networks that is one of the largest providers of post acute care in the United States. From May 2019 to August 2025, Dr. Di Rezze achieved significant growth in revenue and increased provider footprint and quality outcomes through his extensive experience in healthcare operations, financial oversight, and corporate governance. His background combines clinical training with deep strategic and operational expertise across both healthcare delivery and technology innovation. Dr. Di Rezze holds a Bachelor of Arts from the University of Detroit Mercy and a Doctor of Medicine from Wayne State University School of Medicine.
Jtin Di Rezze自2025年9月29日成立以来一直担任公司首席执行官和董事,并且是保荐人Praetorian Sponsor LLC的管理成员,预计将担任公司董事。Di Rezze博士是Theoria Medical的创始人和前任首席执行官,Theoria Medical是一家全国性的医师服务和医疗保健技术组织,业务涵盖专业护理设施、辅助生活中心和远程医疗网络,后者是美国最大的急性后护理提供商之一。从2019年5月到2025年8月,Di Rezze博士通过其在医疗保健运营、财务监督和公司治理方面的丰富经验,实现了收入的显着增长,并增加了供应商的足迹和质量成果。他的背景将临床培训与在医疗保健交付和技术创新方面的深厚战略和运营专业知识相结合。Di Rezze博士拥有底特律仁慈大学的文学学士学位和韦恩州立大学医学院的医学博士学位。Di Rezze将有资格担任首席执行官和董事会成员,这是由于他在构建可扩展的医疗保健企业方面的良好记录、在实施robt治理框架方面的领导能力,以及他对医疗保健、金融和技术融合的全面理解。
Justin Di Rezze has served as Chief Executive Officer and as a director of Company since incorporation on September 29, 2025 and is the managing member of Sponsor, Praetorian Sponsor LLC. Dr. Di Rezze is the founder and former Chief Executive Officer of Theoria Medical, a national physician services and healthcare technology organization operating across skilled nursing facilities, assisted living centers, and telehealth networks that is one of the largest providers of post acute care in the United States. From May 2019 to August 2025, Dr. Di Rezze achieved significant growth in revenue and increased provider footprint and quality outcomes through his extensive experience in healthcare operations, financial oversight, and corporate governance. His background combines clinical training with deep strategic and operational expertise across both healthcare delivery and technology innovation. Dr. Di Rezze holds a Bachelor of Arts from the University of Detroit Mercy and a Doctor of Medicine from Wayne State University School of Medicine.
Alex Elias

Alex Elias预计将担任公司董事。自2011年以来,Elias先生一直担任Qloo Inc.的创始人和首席执行官,这是一家人工智能(“AI”)软件公司,专注于开发和许可跨广泛行业的以隐私为中心的应用程序编程接口(“API”)。通过担任首席执行官,Elias先生在风险评估、数据治理和合规框架方面积累了丰富的经验。Elias先生在南加州大学获得经济学文学学士学位,在纽约大学法学院获得法学博士学位。由于埃利亚斯拥有丰富的人工智能、董事会治理和领导经验,他将有资格担任董事会成员。


Alex Elias has served on Board since the commencement of listing on Nasdaq. Since 2011, Mr. Elias has served as the founder and Chief Executive Officer of Qloo Inc., an artificial intelligence ("AI") software company focused on developing and licensing privacy centric application programming interfaces ("APIs") across a wide range of industries.
Alex Elias预计将担任公司董事。自2011年以来,Elias先生一直担任Qloo Inc.的创始人和首席执行官,这是一家人工智能(“AI”)软件公司,专注于开发和许可跨广泛行业的以隐私为中心的应用程序编程接口(“API”)。通过担任首席执行官,Elias先生在风险评估、数据治理和合规框架方面积累了丰富的经验。Elias先生在南加州大学获得经济学文学学士学位,在纽约大学法学院获得法学博士学位。由于埃利亚斯拥有丰富的人工智能、董事会治理和领导经验,他将有资格担任董事会成员。
Alex Elias has served on Board since the commencement of listing on Nasdaq. Since 2011, Mr. Elias has served as the founder and Chief Executive Officer of Qloo Inc., an artificial intelligence ("AI") software company focused on developing and licensing privacy centric application programming interfaces ("APIs") across a wide range of industries.

高管简历

中英对照 |  中文 |  英文
Peter Ondishin

Peter Ondishin,自2023年3月起担任IPXX的CFO,此前为IPAX员工。Ondishin先生自2023年6月起担任Venture Collective的CFO,自2023年4月起担任IPXX的CFO,自2020年8月起担任Kingstown Capital Management的CFO,此前他曾于2019年4月至2020年8月担任Kingstown的财务总监。Ondishin先生在2016年1月至2019年3月期间担任Atlantic Investment Management的助理财务总监。在此之前,Ondishin先生于2014年1月至2016年1月期间担任Fir Tree Partners的会计师。翁迪辛先生的职业生涯始于普华永道的保险业。Ondishin先生拥有罗格斯大学的学士学位和MBA学位,他也是注册会计师。


Peter Ondishin has been Inflection Point Acquisition Corp. Iii's CFO since November 2024. He has served as CFO of IPXX from March 2023 to March 2025, and he was previously an employee of IPAX. Mr. Ondishin has been the CFO of The Venture Collective since June 2023. He was previously the CFO of Kingstown Capital Management from August 2020 to December 2023 and the Controller of Kingstown from April 2019 to August 2020. Mr. Ondishin was the Assistant Controller for Atlantic Investment Management from January 2016 to March 2019. Before that, Mr. Ondishin worked as an accountant for Fir Tree Partners from January 2014 to January 2016. Mr. Ondishin began his career in assurance at PwC. Mr. Ondishin holds a B.A. and an M.B.A. from Rutgers University, and he is also Certified Public Accountant.
Peter Ondishin,自2023年3月起担任IPXX的CFO,此前为IPAX员工。Ondishin先生自2023年6月起担任Venture Collective的CFO,自2023年4月起担任IPXX的CFO,自2020年8月起担任Kingstown Capital Management的CFO,此前他曾于2019年4月至2020年8月担任Kingstown的财务总监。Ondishin先生在2016年1月至2019年3月期间担任Atlantic Investment Management的助理财务总监。在此之前,Ondishin先生于2014年1月至2016年1月期间担任Fir Tree Partners的会计师。翁迪辛先生的职业生涯始于普华永道的保险业。Ondishin先生拥有罗格斯大学的学士学位和MBA学位,他也是注册会计师。
Peter Ondishin has been Inflection Point Acquisition Corp. Iii's CFO since November 2024. He has served as CFO of IPXX from March 2023 to March 2025, and he was previously an employee of IPAX. Mr. Ondishin has been the CFO of The Venture Collective since June 2023. He was previously the CFO of Kingstown Capital Management from August 2020 to December 2023 and the Controller of Kingstown from April 2019 to August 2020. Mr. Ondishin was the Assistant Controller for Atlantic Investment Management from January 2016 to March 2019. Before that, Mr. Ondishin worked as an accountant for Fir Tree Partners from January 2014 to January 2016. Mr. Ondishin began his career in assurance at PwC. Mr. Ondishin holds a B.A. and an M.B.A. from Rutgers University, and he is also Certified Public Accountant.
Justin Di Rezze

Jtin Di Rezze自2025年9月29日成立以来一直担任公司首席执行官和董事,并且是保荐人Praetorian Sponsor LLC的管理成员,预计将担任公司董事。Di Rezze博士是Theoria Medical的创始人和前任首席执行官,Theoria Medical是一家全国性的医师服务和医疗保健技术组织,业务涵盖专业护理设施、辅助生活中心和远程医疗网络,后者是美国最大的急性后护理提供商之一。从2019年5月到2025年8月,Di Rezze博士通过其在医疗保健运营、财务监督和公司治理方面的丰富经验,实现了收入的显着增长,并增加了供应商的足迹和质量成果。他的背景将临床培训与在医疗保健交付和技术创新方面的深厚战略和运营专业知识相结合。Di Rezze博士拥有底特律仁慈大学的文学学士学位和韦恩州立大学医学院的医学博士学位。Di Rezze将有资格担任首席执行官和董事会成员,这是由于他在构建可扩展的医疗保健企业方面的良好记录、在实施robt治理框架方面的领导能力,以及他对医疗保健、金融和技术融合的全面理解。


Justin Di Rezze has served as Chief Executive Officer and as a director of Company since incorporation on September 29, 2025 and is the managing member of Sponsor, Praetorian Sponsor LLC. Dr. Di Rezze is the founder and former Chief Executive Officer of Theoria Medical, a national physician services and healthcare technology organization operating across skilled nursing facilities, assisted living centers, and telehealth networks that is one of the largest providers of post acute care in the United States. From May 2019 to August 2025, Dr. Di Rezze achieved significant growth in revenue and increased provider footprint and quality outcomes through his extensive experience in healthcare operations, financial oversight, and corporate governance. His background combines clinical training with deep strategic and operational expertise across both healthcare delivery and technology innovation. Dr. Di Rezze holds a Bachelor of Arts from the University of Detroit Mercy and a Doctor of Medicine from Wayne State University School of Medicine.
Jtin Di Rezze自2025年9月29日成立以来一直担任公司首席执行官和董事,并且是保荐人Praetorian Sponsor LLC的管理成员,预计将担任公司董事。Di Rezze博士是Theoria Medical的创始人和前任首席执行官,Theoria Medical是一家全国性的医师服务和医疗保健技术组织,业务涵盖专业护理设施、辅助生活中心和远程医疗网络,后者是美国最大的急性后护理提供商之一。从2019年5月到2025年8月,Di Rezze博士通过其在医疗保健运营、财务监督和公司治理方面的丰富经验,实现了收入的显着增长,并增加了供应商的足迹和质量成果。他的背景将临床培训与在医疗保健交付和技术创新方面的深厚战略和运营专业知识相结合。Di Rezze博士拥有底特律仁慈大学的文学学士学位和韦恩州立大学医学院的医学博士学位。Di Rezze将有资格担任首席执行官和董事会成员,这是由于他在构建可扩展的医疗保健企业方面的良好记录、在实施robt治理框架方面的领导能力,以及他对医疗保健、金融和技术融合的全面理解。
Justin Di Rezze has served as Chief Executive Officer and as a director of Company since incorporation on September 29, 2025 and is the managing member of Sponsor, Praetorian Sponsor LLC. Dr. Di Rezze is the founder and former Chief Executive Officer of Theoria Medical, a national physician services and healthcare technology organization operating across skilled nursing facilities, assisted living centers, and telehealth networks that is one of the largest providers of post acute care in the United States. From May 2019 to August 2025, Dr. Di Rezze achieved significant growth in revenue and increased provider footprint and quality outcomes through his extensive experience in healthcare operations, financial oversight, and corporate governance. His background combines clinical training with deep strategic and operational expertise across both healthcare delivery and technology innovation. Dr. Di Rezze holds a Bachelor of Arts from the University of Detroit Mercy and a Doctor of Medicine from Wayne State University School of Medicine.